Form 4: Zimmer Biomet CFO Suketu Upadhyay Reports Stock Transactions

Suketu Upadhyay, CFO of Zimmer Biomet Holdings, Inc., reports the vesting of restricted stock units and subsequent tax withholding, resulting in changes to his beneficial ownership of company stock.

Summary

• On March 6, 2025, Suketu Upadhyay, the CFO of Zimmer Biomet Holdings, Inc., had 4,560 restricted stock units (RSUs) vest.
• Upon vesting, Upadhyay acquired 4,560 shares of common stock.
• Simultaneously, 2,029 shares were withheld by the company to cover tax obligations at a price of $104.86 per share.
• Following these transactions, Upadhyay directly owns 48,853 shares of common stock and 4,559 restricted stock units.
• The remaining RSUs will vest on March 6, 2026.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing stock transactions, and carries a neutral sentiment.

Future Outlook

The remaining restricted stock units will vest on March 6, 2026.

Industry Context

This Form 4 filing is a routine disclosure required by the SEC when company insiders, like the CFO, engage in transactions involving the company's stock. It provides transparency to investors regarding the ownership positions of key executives.

Stakeholder Impact

• The filing provides transparency to shareholders regarding executive stock ownership.
• The transactions have a negligible impact on employees, customers, suppliers, and creditors.

Key Dates